{"disease":{"id":"enteropathy","name":"enteropathy"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"odsh-at-0-125-mg-kg-h","indication_name":"Protein-Losing Enteropathy Secondary to Single Ventricle","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ODSH at 0.125 mg/kg/h","company_name":"Jazz Pharmaceuticals","drug_phase":"discontinued","molecular_target":"Intestinal lymphatic proteins (albumin, immunoglobulins); mechanism targets protein loss pathway in enteropathy","drug_class":"Protein sequestrant; modified polysaccharide; orphan therapeutic","quality_score":null,"revenue":null,"mechanism":"ODSH is a modified chitosan polymer that binds intestinal lymphatic proteins to reduce protein loss in enteropathy."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06524947","title":"Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6600,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT03208725","title":"Childhood Acute Illness and Nutrition Network","phase":"","overall_status":"UNKNOWN","enrollment_count":4335,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03713502","title":"Enteropathy and Diabetes in HIV Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1947,"lead_sponsor_name":"National Institute for Medical Research, Tanzania","has_results":false},{"nct_id":"NCT05978141","title":"A Registry for People With T-cell Lymphoma","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT01787409","title":"Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":565,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03588013","title":"Study of Environmental Enteropathy and Malnutrition in Pakistan","phase":"NA","overall_status":"COMPLETED","enrollment_count":416,"lead_sponsor_name":"Aga Khan University","has_results":false},{"nct_id":"NCT01571505","title":"Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"International Vaccine Institute","has_results":false},{"nct_id":"NCT01374490","title":"Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT06497907","title":"Environmental Enteropathy Among Infants and Children With Growth Faltering","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04280510","title":"Pathogenic Study of Adult Immune Enteropathies","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT04528303","title":"Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT04803201","title":"Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":170,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT04462978","title":"Non-Immunoglobulin E-mediated Food Allergies in Children","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT02010268","title":"Use of Faecal Calprotectin to Predict Enteropathy of the Preterm Neonates","phase":"NA","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03462979","title":"Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease","phase":"NA","overall_status":"SUSPENDED","enrollment_count":120,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT05608928","title":"Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":76,"lead_sponsor_name":"Tropical Gastroenterology & Nutrition Group (TROPGAN)","has_results":false},{"nct_id":"NCT05720442","title":"Efficacy Assessment of Chinese Herbal Medicine Tangweian Recipe Treating Participants With Diabetic Gastroenteropathy","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT07055477","title":"A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03288831","title":"Changes in Intestinal Permeability 4 Hours After Gluten Challenge","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT00697346","title":"Study of MLN8237 in Participants With Advanced Hematological Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04981262","title":"Improved Quality of Life in Children With Intestinal Failure","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT02561273","title":"Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"University of Nebraska","has_results":true},{"nct_id":"NCT04885751","title":"Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Seoul National University Boramae Hospital","has_results":false},{"nct_id":"NCT03113500","title":"Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48,"lead_sponsor_name":"City of Hope Medical Center","has_results":true},{"nct_id":"NCT06038344","title":"Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT06340828","title":"Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"The Second Hospital of Nanjing Medical University","has_results":false},{"nct_id":"NCT02652715","title":"Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03049449","title":"T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT07284641","title":"Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT02588651","title":"A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Deepa Jagadeesh","has_results":true},{"nct_id":"NCT01590732","title":"Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02895438","title":"Non Coeliac Gluten Sensitivity in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT05474664","title":"Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04565821","title":"Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03217643","title":"CHP-BV Followed by Consolidation With High-dose Therapy / ASCT as Frontline Treatment of Patients With EATL Type 1.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Imagine Institute","has_results":false},{"nct_id":"NCT03598998","title":"Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":13,"lead_sponsor_name":"City of Hope Medical Center","has_results":true},{"nct_id":"NCT03075553","title":"Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT04209634","title":"Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT04480788","title":"CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"PersonGen BioTherapeutics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT06701344","title":"Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":7,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05377827","title":"Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02199496","title":"Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT01893775","title":"Antibody Treatment for Advanced Celiac Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03866538","title":"Budesonide in Patients With Immune Mediated Enteropathies","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT04639843","title":"Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06692452","title":"Tazemetostat Plus CHOP in 1L T-cell Lymphoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Eric Jacobsen, MD","has_results":false},{"nct_id":"NCT05232110","title":"Compassionate Use of Pozelimab","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT06003881","title":"Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":48},"guidelines":[],"source":"Drug Landscape verified database"}